Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 11-20 of 91

Page
per page
  1. Otenabant
    A3691 Otenabant
    Summary: CB1 receptor antagonist
      Soluble in DMSO
  2. Rimonabant hydrochloride
    A3766 Rimonabant hydrochloride
    Summary: CB1 receptor inverse agonist
      insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
  3. Taranabant
    A3858 Taranabant
    Summary: Cannabinoid receptor type 1 inverse agonist
      Soluble in DMSO
  4. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40 agonist
      insoluble in H2O; ≥11.85 mg/mL
  5. AM630
    A3168 AM630
    Summary: CB2 receptor antagonist,selective and competitive
      ≥25.2 mg/mL
  6. (R)-(+)-Atenolol
    C3031 (R)-(+)-Atenolol
    Summary: less active enantiomer of the racemic β1-adrenergic receptor antagonist, (R,S)-atenolol.
      ≤5 mg/mL
  7. CCG-63802
    A3289 CCG-63802
    Summary: RGS protein inhibitor
      soluble in DMSO
  8. CRF (6-33)
    B5148 CRF (6-33)
    Summary: Corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide
      Soluble to 1 mg/mL
  9. Perindopril
    B1214 Perindopril
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE inhibitor
      Soluble in DMSO
  10. AHU-377(Sacubitril)
    B1070 AHU-377(Sacubitril)
    Target: neprilysin
    Summary: Neprilysin inhibitor
      ≥41.1 mg/mL

Items 11-20 of 91

Page
per page
Shop By
Now Shopping by
  1. Category GPCR/G protein Remove This Item
Clear All
Shopping Options
Category
  1. 5-HT Receptor 19item
  2. Adenosine Receptor 5item
  3. Adenosine Kinase 3item
  4. Adrenergic Receptor 8item
  5. Adrenergic Transporters 4item
  6. Angiotensin Receptor 6item
  7. Cannabinoid Receptor 8item
  8. CXCR 4item
  9. EP4 Receptor 1 item
  10. ETA Receptors 1 item
  11. Free Fatty Acid Receptors 5item
  12. Glucagon Receptor 1 item
  13. GPR109A 1 item
  14. GPR120 2item
  15. GPR35 1 item
  16. Leukotriene Receptor 1 item
  17. LPL Receptor 1 item
  18. mGluR 1 item
  19. Non-selective CRF 1 item
  20. NOP Receptor 1 item
  21. P2Y Receptor 1 item
  22. Peptide Receptors 1 item
  23. PGD2 Receptor 1 item
  24. Prostaglandin Receptor 2item
  25. Prostanoid Receptors 1 item
  26. Protease-Activated Receptors 1 item
  27. RGS 2item
  28. S1P receptor 2item
  29. Vasopressin Receptor 1 item
  30. 17,20-lyase 1 item
  31. Ras 3item
  32. S1P receptor inhibitor 1 item
Specificity
  1. Selective 22item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. CXCR 4item
  2. Voltage-gated Potassium (KV) Channels 1 item
  3. Trk Receptors 1 item
  4. Angiotensin AT2 Receptors 1 item
  5. Adenosine Kinases 2item
  6. 5-HT2 Receptors 3item
  7. Insulin and Insulin-like Receptors 1 item
  8. Sphingosine kinases (SphKs) 2item
  9. D2 Receptors 1 item
  10. 5-HT1 Receptors 1 item
  11. 5-HT7 Receptors 1 item
  12. Serotonin reuptake 1 item
  13. Angiotensin-Converting Enzymes (ACEs) 1 item
  14. Free Fatty Acid Receptors 2item
  15. Norepinephrine transporter 1 item
  16. 5-HT Transporters 2item
  17. Norepinephrine transporters 1 item
  18. Angiotensin AT1 Receptors 1 item
  19. Na /Ca2 Exchangers (NCXs) 1 item
  20. GPR40 1 item
  21. Glucagon Receptors 1 item
  22. neprilysin 1 item
  23. 5-HT4 Receptor 1 item
  24. Adenosine Deaminases 1 item
  25. Serotonin (5-HT) reuptake 1 item
Reported Experiments
  1. Animal Experiments 26item
  2. Cell Experiments 18item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Bladder Diseases 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 3item
  5. Cancer 9item
  6. Colorectal Cancer 3item
  7. Depression 1 item
  8. Heart Failure 1 item
  9. HIV Infections 1 item
  10. Inflammatory Diseases 1 item
  11. Kidney Injury Studies 1 item
  12. Leukemia 1 item
  13. Lymphoma 1 item
  14. Schizophrenia 2item
  15. Squamous Cell Carcinoma 1 item
  16. Type 2 Diabetes 3item